Carlisle Companies (NYSE: CSL) VP awarded restricted stock and options

Rhea-AI Filing Summary

Carlisle Companies executive Juan Sifontes, VP of Carlisle Operating System, reported equity awards from the company. On January 28, 2026, he received 220 shares of common stock as a restricted stock grant, increasing his directly owned common shares to 720.

He was also granted an employee stock option for 770 shares of Carlisle common stock at an exercise price of $341.01 per share. This option becomes exercisable in three equal annual installments beginning on January 28, 2027, and covers 770 shares held as a direct derivative position.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sifontes Juan

(Last) (First) (Middle)

16430 N SCOTTSDALE RD

STE 400

(Street)

SCOTTSDALE AZ 85254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CARLISLE COMPANIES INC [ CSL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Carlisle Operating System

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		A		220(1)	A	$0	720	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$341.01	01/28/2026		A		770		(2)	01/27/2036	Common Stock	770	$0	770	D

Explanation of Responses:

1. Represents a grant of 220 restricted shares from the issuer as an executive officer of the issuer.

2. The option vests in three equal annual installments beginning on January 28, 2027.

Remarks:

	/s/ Juan Sifontes by Ronald P. Fuss, attorney-in-fact	01/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Carlisle Companies (CSL) report for Juan Sifontes?

Carlisle Companies reported that VP Juan Sifontes received equity awards on January 28, 2026. He was granted 220 restricted common shares and an employee stock option for 770 shares, both reported as directly owned positions after the transactions.

How many Carlisle Companies shares does Juan Sifontes own after this Form 4?

After the reported grant, Juan Sifontes directly owns 720 shares of Carlisle common stock. In addition, he holds an employee stock option covering 770 shares, which provides the right to purchase further shares subject to its vesting schedule and exercise price.

What are the terms of Juan Sifontes’ Carlisle employee stock option grant?

The employee stock option gives Juan Sifontes the right to buy 770 Carlisle common shares at an exercise price of $341.01 per share. The option vests in three equal annual installments starting on January 28, 2027, extending through subsequent years.

What type of equity award is the 220-share grant to Juan Sifontes at Carlisle?

The 220-share grant is described as restricted common stock awarded to Juan Sifontes in his role as an executive officer. Restricted shares typically are subject to service or time-based conditions before fully vesting and becoming freely transferable by the recipient.

Is the Form 4 for Carlisle VP Juan Sifontes a purchase or a grant?

The Form 4 reflects grants, not open-market purchases. Juan Sifontes was awarded 220 restricted shares and an employee stock option for 770 shares, both reported at a transaction price of $0, indicating issuer-granted compensation rather than a cash purchase.